When transformed by viruses, chemicals, or x-ray, malignant cells of the mouse express a cellular protein with a Mr of 53,000 (1, 2) . This component, designated p53, was identified in [35s]methionine-labeled cell extracts by immunoprecipitation with syngeneic antisera prepared against methylcholanthreneinduced sarcoma cells. Detectable levels of p53 were not found in a broad range of normal cell types, including mouse embryo cells, adult fibroblasts, spleen cells, and bone marrow cells. Extracts of normal thymus, however, were found to express p53. Lane and Crawford (3), Linzer and Levine (4) , and Melero et aL (5) identified proteins with related characteristics in their studies of simian viruses 40 (SV40)-transformed cells. By virtue of its affinity for SV40 tumor antigen, p53 is coprecipitated from extracts of SV40-transformed cells by anti-tumor antigen antibody. A Mr 53,000 protein has also been detected by Luka et aL (6) in transformed B cells of human origin but not in nontransformed B cells. In cell lines carrying the Epstein-Barr virus-directed EBNA antigen, the Mr 53,000 component forms a complex with EBNA. In this report, we characterize a monoclonal antibody to mouse p53 by immunoprecipitation and immunofluorescence (IF) assays. This antibody identifies a serologically related component in human cells, and this has permitted us to survey normal and malignant human cells for p53 expression. tissue culture slides (VWR Scientific). At varying intervals after plating, the cells were washed in phosphate-buffered saline, fixed in methanoVacetone, 1:1 (vol/vol), at -20'C for 5 min, and air dried for 20 min. To each well was added 100 A.l of mouse serum containing p53 monoclonal antibody (diluted 1:50 or 1:100) and the slides were incubated for 60 min at 240C. After removal of mouse serum by washing, the cells were treated with a 1:15 dilution of fluorescein isothiocyanate-conjugated F (ab')2 fragments of rabbit Ig anti-mouse Ig (Cappel Laboratories, Cochranville, PA) for 45 min at 240C, washed, and examined by fluorescence microscopy (Leitz).
MATERIALS AND METHODS
[ Table 2 summarizes the results of IF tests with the p53 monoclonal antibody on a panel of human cell types. Both normal and malignant human cells were found to react with p53 antibody. Fig. 4 a-c illustrates IF reactions with SK-MEL-64 and SK-MEL-28, two established lines of malignant melanoma. As in the mouse, fluorescence was confined to the nucleus and usually occurred in irregular patches rather than as homogeneous staining throughout the nucleus. Fig. 4d illustrates the similar pattern of fluorescence in rapidly growing early passages of normal kidney epithelium. Eighty to 90% of these cells showed strong nuclear fluorescence. After reaching confluence, cultures of normal kidney cells showed strong contact inhibition; associated with cessation of cell division, p53 nuclear fluorescence disappeared (Fig. 4e) . Accompanying this loss of nuclear fluorescence, confluent cultures of kidney epithelium developed a weak, diffuse cytoplasmic fluorescence. Cultures of fetal brain also showed strong nuclear fluorescence with p53 monoclonal antibody during the active growth phase of the cells, followed by loss of nuclear fluorescence and the development of cytoplasmic fluorescence after the cultures reached confluence. Malignant cells, such as SK-MEL-64 and renal cancers SK-RC-2 and SK-RC-9, which do not show contact inhibition of cell division, behaved quite differently in this regard. Nuclear fluorescence did not disappear after the cultures reached confluence (Fig.  4b) . Rather, p53 expression persisted as the cells continued to divide and pile up. However, conditions that lead to reduced growth rates of cultures of malignant cells can cause p53 levels to fall. SK-MEL-64 melanoma cells growing optimally in 15% fetal calf serum showed strong nuclear fluorescence. Replacing the medium in such cultures with media containing less fetal calf serum (-7.5%) caused a rapid decrease in cell division and an 80-90% reduction in numbers of cells expressing p53.
DISCUSSION
The molecular weight and tryptic peptide map of the mouse p53 component detected by the monoclonal antibody characterized in this repcrt correspond precisely to the component defined in our original study with hyperimmune antisera. As measured by immunoprecipitation of labeled extracts, the monoclonal antibody and the conventional antibody show the same pattern of p53 expression in various normal and malignant mouse cells. The monoclonal antibody also permits clear-cut detection of p53 by indirect IF, and this provides a way to measure p53 in individual cells. Expression of p53 appears to be generally restricted to the nucleus, and different cell types show considerable variation in the level of detectable p53. In the mouse, SV40-transformed 3T3 cells and certain methylcholanthreneinduced tumors, such as Meth A, express high levels of p53 whereas leukemia cells express much lower amounts. The predominantly transformation-related pattern of p53 in the mouse as originally described by using immunoprecipitation analysis is also seen with IF. Cultures of embryo cells, adult lung fibroblasts, nontransformed 3T3 cells, and T cells growing in the presence of TCGF are negative for p53 expression. No p53 could be detected by IF in frozen sections of normal thymus or in thymic imprints, despite the fact that p53 is demonstrable in extracts of thymus by immunoprecipitation. This may be due to low levels of p53 throughout the thymus or high levels in a restricted cell population that was not identified in our IF studies.
An additional benefit of the p53 monoclonal antibody is that it detects a serologically related component in certain human cells, and recent characterization of the crossreacting antigen in SK-MEL-64 melanoma shows that it has an Mr of approximately 55,000. IF tests reveal the presence of this component in various cell lines derived from human cancer and, similar to our observations with mouse tumors, the antigen usually is found in the nucleus and varies in strength of expression in the different cell lines. Human p53 is also easily detected in certain cultured normal cells, such as rapidly dividing kidney epithehum and cells derived from fetal brain. In both normal and malignant cells, expression of p53 was strongly influenced by culture conditions. For instance, levels of p53 that were characteristically high in SK-MEL-64 cells growing optimally in medium supplemented with 15% fetal calf serum show a rapid fall in media supplemented with lower concentrations of serum, and this decrease in p53 expression is associated with a corresponding reduction in cell division in such cultures.
This relationship of cell division and p53 expression is also strikingly evident in the case of cultured normal kidney epithelium. These cells, which grow vigorously during their initial two or three subcultures in vitro, are subject to strong contact inhibition upon reaching confluence. Expression of nuclear p53 correlates directly with the growth characteristics of these cultures-i.e., high levels during the period of rapid cell division and low to undetectable levels in confluent cultures. With its loss from the nucleus, p53 becomes demonstrable in the cytoplasm of contact-inhibited cultures of normal kidney and fetal brain, possibly indicating that p53 continues to be synthesized under these conditions but is not transported to the nucleus. In contrast to these findings with normal cells, in malignant lines, such as SK-MEL-64, p53 levels tend to remain high after cultures reach confluence and cells begin to overgrow the monolayer.
These observations suggest that p53 may be involved in the regulation of cell division, possibly as one of the factors initiating DNA synthesis. In normal cells, p53 would be under the control of signals that normally regulate cell division, as shown by the decrease in p53 levels in the nucleus coincidental with density-dependent inhibition of cell growth. To probe possible causal associations between p53 and cell division, it will be important to know if p53 is synthesized at a specific point in the cell cycle or if its synthesis is independent of the cell cycle.
Proc. NatL Acad. Sci. USA 78 (1981) 1699 Comparable questions will need to be asked about p53 transport and turnover. In malignant cells, p53 expression and cell division are not regulated by contact inhibition (although they continue to be influenced by growth stimuli in the culture medium). In addition, especially in the case of the mouse, levels of p53 are generally higher in neoplastic cells than in normal cells. The nature of the regulatory defect that leads to persistent high levels of p53 in transformed cells is a key issue for future study. In the case of cells transformed by viruses, following the model of SV40 in which tumor antigen forms a complex with p53 antigen, transforming protein may interact with p53 in such a way as to impede the rate of p53 breakdown or alter the regulatory circuit controlling p53 synthesis among several possibilities. In the case of cells transformed by other means, endogenous products may be found with p53-binding activity similar to virus-encoded transforming proteins.
Note Added in Proof. p53 monoclonal antibodies have now been described by two other groups (14, 15 
